Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes
I. Zehbe et al., Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes, INT J CANC, 94(5), 2001, pp. 711-716
Infection with high-risk human papillomavirus (HPV) is necessary for the de
velopment of a cervical lesion, but only a fraction of precursor lesions pr
ogress to cancer. Additional factors, other than HPV type per se, are likel
y to increase the probability for progression. Intratype genome variations
have been reported to be associated with viral persistence and the developm
ent of a major cervical disease. We have recently shown that the prevalence
of specific HPV16-E6 variants in invasive cervical cancer (ICC) varies bet
ween Italian and Swedish women. To extend our initial study we have analyze
d E6 variants in cervical lesions from Czech women, ranging from low-grade
cervical intraepithelial neoplasia (LCIN) to ICC and scaled up the sample s
ize of our initial study of Swedish and Italian women. In addition, we have
correlated the cases of cancers with human leukocyte antigen (HLA) class I
I haplotypes. In line with our earlier observation, the distribution of spe
cific HPVI6-E6 genotypes in CIN and ICC varied in the 3 cohorts. For instan
ce, the HPV16-E6 L83V variant, which has been found to be positively associ
ated with ICC in Swedish women (p=0.002), was more prevalent in LCIN than i
n ICC in Italian and Czech women (p=0.01 and = 0.03, respectively). These d
ata indicate that host genetic factors, such as HLA polymorphism, may deter
mine the potential oncogenicity of the HPVI6-E6 L83V variant. Indeed, the D
R04-DQ03 haplotype, which is approximately 3-fold more abundant in the norm
al Swedish population than in those in Italy and the Czech Republic, was fo
und to be positively associated with HPVI6-E6 L83V in the 3 cohorts investi
gated (p=0.01). This observation may explain why L83V is a risk factor more
in Sweden than in the other 2 countries. (C) 2001 Wiley-Liss, Inc.